These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 29524933)
1. Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals. Gleeson D; Menkes DB Int J Health Policy Manag; 2018 Feb; 7(2):98-100. PubMed ID: 29524933 [TBL] [Abstract][Full Text] [Related]
2. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health. Labonté R; Crosbie E; Gleeson D; McNamara C Global Health; 2019 May; 15(1):35. PubMed ID: 31088499 [TBL] [Abstract][Full Text] [Related]
3. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts. Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767 [TBL] [Abstract][Full Text] [Related]
4. The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications. Mackey TK; Cuomo RE; Liang BA BMC Health Serv Res; 2015 Jun; 15():236. PubMed ID: 26084705 [TBL] [Abstract][Full Text] [Related]
5. A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement. Friel S; Gleeson D; Thow AM; Labonte R; Stuckler D; Kay A; Snowdon W Global Health; 2013 Oct; 9():46. PubMed ID: 24131595 [TBL] [Abstract][Full Text] [Related]
6. Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study. Schulz PJ; Crosignani F; Petrocchi S J Med Internet Res; 2023 Jul; 25():e40616. PubMed ID: 37459159 [TBL] [Abstract][Full Text] [Related]
7. The Trans-Pacific Partnership: Is It Everything We Feared for Health? Labonté R; Schram A; Ruckert A Int J Health Policy Manag; 2016 Aug; 5(8):487-496. PubMed ID: 27694662 [TBL] [Abstract][Full Text] [Related]
8. Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease. Eisenberg MD; Singh Y; Sood N JAMA Health Forum; 2022 Aug; 3(8):e222570. PubMed ID: 36200632 [TBL] [Abstract][Full Text] [Related]
9. The legal and ethical dimensions of direct-to-consumer advertising of prescription drugs: the case of Pfizer and Lipitor in the United States. Koku PS Health Mark Q; 2021; 38(1):23-34. PubMed ID: 34219606 [TBL] [Abstract][Full Text] [Related]
10. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Mintzes B Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883 [TBL] [Abstract][Full Text] [Related]
11. Is exposure to pharmaceutical direct-to-consumer advertising for heart disease and diabetes associated with physical activity and dietary behavior? Niederdeppe J; Avery RJ; Liu J; Mann C; Sood N; Eisenberg MD Soc Sci Med; 2023 Aug; 330():116062. PubMed ID: 37418992 [TBL] [Abstract][Full Text] [Related]
13. A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea. Yang YM; Lee JJ; Jeong E; Kim SY; Han MA; Choi EJ PLoS One; 2018; 13(7):e0201108. PubMed ID: 30040833 [TBL] [Abstract][Full Text] [Related]
14. Trade agreements and the risks for the nursing workforce, nursing practice and public health: A scoping review. Kidgell D; Hills D; Griffiths D; Endacott R Int J Nurs Stud; 2020 Sep; 109():103676. PubMed ID: 32603925 [TBL] [Abstract][Full Text] [Related]
15. Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws. Nathenson R; Richards MR Int J Health Econ Manag; 2018 Sep; 18(3):321-336. PubMed ID: 29380108 [TBL] [Abstract][Full Text] [Related]
16. Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization. Gray MP; San-Juan-Rodriguez A; Chen N; Good CB; Hernandez I Res Social Adm Pharm; 2020 Aug; 16(8):1136-1139. PubMed ID: 31864886 [TBL] [Abstract][Full Text] [Related]
17. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Rollins BL Int J Health Policy Manag; 2016 Feb; 5(4):287-8. PubMed ID: 27239875 [TBL] [Abstract][Full Text] [Related]
18. Can direct-to-consumer advertising of prescription drugs be effectively regulated? Lexchin J; Menkes DB N Z Med J; 2019 Jun; 132(1496):59-65. PubMed ID: 31170134 [TBL] [Abstract][Full Text] [Related]
19. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016. Liu J; Avery RJ; Kim JJ; Niederdeppe J J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131 [TBL] [Abstract][Full Text] [Related]
20. Direct-to-consumer prescription medication advertisements and obtaining prescriptions with or without a doctor's prescription. Fogel J; Zhuk A Health Mark Q; 2019; 36(3):220-235. PubMed ID: 31267822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]